- Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas
-
Mazumder S, Swank V, Dvorina N, Johnson JM, Tuohy VK
- KMID: 2534987
- Clin Exp Vaccine Res.
- 2022 May;11(2):163-172.
- doi: 10.7774/cevr.2022.11.2.163
Purpose Epithelial ovarian carcinoma (EOC) is the most lethal of all human gynecologic malignancies. We previously reported that vaccination of female mice with the extracellular domain of anti-Müllerian hormone receptor II... -
- CITED
-
- Close
- SHARE
-
- Close
